BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18783951)

  • 1. Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase.
    Mao J; Eoh H; He R; Wang Y; Wan B; Franzblau SG; Crick DC; Kozikowski AP
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5320-3. PubMed ID: 18783951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
    Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
    Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K
    Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, cloning, purification, and enzymatic characterization of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase.
    Bailey AM; Mahapatra S; Brennan PJ; Crick DC
    Glycobiology; 2002 Dec; 12(12):813-20. PubMed ID: 12499403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
    Ali MA; Yar MS
    Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
    Bacelar AH; Carvalho MA; Proença MF
    Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
    Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
    J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
    Fullam E; Talbot J; Abuhammed A; Westwood I; Davies SG; Russell AJ; Sim E
    Bioorg Med Chem Lett; 2013 May; 23(9):2759-64. PubMed ID: 23518278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity.
    Singh K; Singh K; Wan B; Franzblau S; Chibale K; Balzarini J
    Eur J Med Chem; 2011 Jun; 46(6):2290-4. PubMed ID: 21450375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents.
    Ballell L; Field RA; Chung GA; Young RJ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1736-40. PubMed ID: 17239593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
    Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and mycobacterial evaluation of 5-substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one derivatives.
    Agre N; Degani M; Gupta A; Bhakta S; Ray MK
    Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900068. PubMed ID: 31339194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis.
    Samala G; Brindha Devi P; Saxena S; Gunda S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Nov; 24(21):5556-5564. PubMed ID: 27667550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds.
    Verbitskiy EV; Cheprakova EM; Slepukhin PA; Kravchenko MA; Skornyakov SN; Rusinov GL; Chupakhin ON; Charushin VN
    Eur J Med Chem; 2015 Jun; 97():225-34. PubMed ID: 25982331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
    Ducray R; Ballard P; Barlaam BC; Hickinson MD; Kettle JG; Ogilvie DJ; Trigwell CB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):959-62. PubMed ID: 18182285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.